<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33694050</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>13</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1459</ISSN><JournalIssue CitedMedium="Internet"><Volume>268</Volume><Issue>9</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of neurology</Title><ISOAbbreviation>J Neurol</ISOAbbreviation></Journal><ArticleTitle>Prognostic models for amyotrophic lateral sclerosis: a systematic review.</ArticleTitle><Pagination><StartPage>3361</StartPage><EndPage>3370</EndPage><MedlinePgn>3361-3370</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00415-021-10508-7</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Increasing prognostic models for amyotrophic lateral sclerosis (ALS) have been developed. However, no comprehensive evaluation of these models has been done. The purpose of this study was to map the prognostic models for ALS to assess their potential contribution and suggest future improvements on modeling strategy.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Databases including Medline, Embase, Web of Science, and Cochrane library were searched from inception to 20 February 2021. All studies developing and/or validating prognostic models for ALS were selected. Information regarding modelling method and methodological quality was extracted.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 28 studies describing the development of 34 models and the external validation of 19 models were included. The outcomes concerned were ALS progression (n&#x2009;=&#x2009;12; 35%), change in weight (n&#x2009;=&#x2009;1; 3%), respiratory insufficiency (n&#x2009;=&#x2009;2; 6%), and survival (n&#x2009;=&#x2009;19; 56%). Among the models predicting ALS progression or survival, the most frequently used predictors were age, ALS Functional Rating Scale/ALS Functional Rating Scale-Revised, site of onset, and disease duration. The modelling method adopted most was machine learning (n&#x2009;=&#x2009;16; 47%). Most of the models (n&#x2009;=&#x2009;25; 74%) were not presented. Discrimination and calibration were assessed in 12 (35%) and 2 (6%) models, respectively. Only one model by Westeneng et al. (Lancet Neurol 17:423-433, 2018) was assessed with overall low risk of bias and it performed well in both discrimination and calibration, suggesting a relatively reliable model for practice.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study systematically reviewed the prognostic models for ALS. Their usefulness is questionable due to several methodological pitfalls and the lack of external validation done by fully independent researchers. Future research should pay more attention to the addition of novel promising predictors, external validation, and head-to-head comparisons of existing models.</AbstractText><CopyrightInformation>&#xa9; 2021. Springer-Verlag GmbH Germany, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Xu</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, 38 Xueyuan Road, Haidian District, Beijing, 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>He</LastName><ForeName>Bingjie</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, 38 Xueyuan Road, Haidian District, Beijing, 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yunjing</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, 38 Xueyuan Road, Haidian District, Beijing, 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking University Third Hospital, 49 Huayuan North Road, Haidian District, Beijing, 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Dongsheng</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Neurology, Peking University Third Hospital, 49 Huayuan North Road, Haidian District, Beijing, 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhan</LastName><ForeName>Siyan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, 38 Xueyuan Road, Haidian District, Beijing, 100191, China. siyan-zhan@bjmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center of Clinical Epidemiology, Peking University Third Hospital, 49 North Garden Road, Haidian District, Beijing, 100191, China. siyan-zhan@bjmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Intelligent Public Health, Institute for Artificial Intelligence, Peking University, 38 Xueyuan Road, Haidian District, Beijing, 100191, China. siyan-zhan@bjmu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Shengfeng</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, School of Public Health, Peking University, 38 Xueyuan Road, Haidian District, Beijing, 100191, China. shengfeng1984@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>91646107</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>81973146</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>2018YFC1311704</GrantID><Agency>National Key Research and Development Program of China</Agency><Country/></Grant><Grant><GrantID>DQGG0404</GrantID><Agency>National research program for key issues in air pollution control</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>J Neurol</MedlineTA><NlmUniqueID>0423161</NlmUniqueID><ISSNLinking>0340-5354</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015982" MajorTopicYN="N">Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="N">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012131" MajorTopicYN="Y">Respiratory Insufficiency</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Motor neuron disease</Keyword><Keyword MajorTopicYN="N">Neurodegenerative diseases</Keyword><Keyword MajorTopicYN="N">Prognostic model</Keyword><Keyword MajorTopicYN="N">Systematic review</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>12</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>3</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>11</Day><Hour>7</Hour><Minute>9</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33694050</ArticleId><ArticleId IdType="doi">10.1007/s00415-021-10508-7</ArticleId><ArticleId IdType="pii">10.1007/s00415-021-10508-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown RH, Al-Chalabi A (2017) Amyotrophic lateral sclerosis. N Engl J Med 377:162&#x2013;172. https://doi.org/10.1056/NEJMra1603471</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw PJ, Simmons Z, van den Berg LH (2017) Amyotrophic lateral sclerosis. Nat Rev Dis Primers 3:17071. https://doi.org/10.1038/nrdp.2017.85</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.85</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G, Piccininni M, Marin B, Nichols E, Abd-Allah F, Abdelalim A, Alahdab F, Asgedom SW, Awasthi A, Chaiah Y, Daryani A, Do HP, Dubey M, Elbaz A, Eskandarieh S, Farhadi F, Farzadfar F, Fereshtehnejad S-M, Fernandes E, Filip I, Foreman KJ, Gebre AK, Gnedovskaya EV, Hamidi S, Hay SI, Irvani SSN, Ji JS, Kasaeian A, Kim YJ, Mantovani LG, Mashamba-Thompson TP, Mehndiratta MM, Mokdad AH, Nagel G, Nguyen TH, Nixon MR, Olagunju AT, Owolabi MO, Piradov MA, Qorbani M, Radfar A, Reiner RC, Sahraian MA, Sarvi S, Sharif M, Temsah O, Tran BX, Truong NT, Venketasubramanian N, Winkler AS, Yimer EM, Feigin VL, Vos T, Murray CJL (2018) Global, regional, and national burden of motor neuron diseases 1990&#x2013;2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17:1083&#x2013;1097. https://doi.org/10.1016/s1474-4422(18)30404-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(18)30404-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamin M, Bede P, Montuschi A, Pender N, Chio A, Hardiman O (2015) Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm. J Neurol 262:1447&#x2013;1454. https://doi.org/10.1007/s00415-015-7731-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-015-7731-6</ArticleId><ArticleId IdType="pubmed">25860344</ArticleId><ArticleId IdType="pmc">4469087</ArticleId></ArticleIdList></Reference><Reference><Citation>Knibb JA, Keren N, Kulka A, Leigh PN, Martin S, Shaw CE, Tsuda M, Al-Chalabi A (2016) A clinical tool for predicting survival in ALS. J Neurol Neurosurg Psychiatry 87:1361&#x2013;1367. https://doi.org/10.1136/jnnp-2015-312908</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-312908</ArticleId><ArticleId IdType="pubmed">27378085</ArticleId></ArticleIdList></Reference><Reference><Citation>Moons KG, de Groot JA, Bouwmeester W, Vergouwe Y, Mallett S, Altman DG, Reitsma JB, Collins GS (2014) Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist. PLoS Med 11:e1001744. https://doi.org/10.1371/journal.pmed.1001744</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001744</ArticleId><ArticleId IdType="pubmed">25314315</ArticleId><ArticleId IdType="pmc">4196729</ArticleId></ArticleIdList></Reference><Reference><Citation>Zandon&#xe0; A, Vasta R, Chi&#xf2; A, Di Camillo B (2019) A dynamic bayesian network model for the simulation of amyotrophic lateral sclerosis progression. BMC Bioinformatics 20:118. https://doi.org/10.1186/s12859-019-2692-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-019-2692-x</ArticleId><ArticleId IdType="pubmed">30999865</ArticleId><ArticleId IdType="pmc">6471677</ArticleId></ArticleIdList></Reference><Reference><Citation>Carreiro AV, Amaral PMT, Pinto S, Tom&#xe1;s P, de Carvalho M, Madeira SC (2015) Prognostic models based on patient snapshots and time windows: predicting disease progression to assisted ventilation in Amyotrophic Lateral Sclerosis. J Biomed Inform 58:133&#x2013;144. https://doi.org/10.1016/j.jbi.2015.09.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2015.09.021</ArticleId><ArticleId IdType="pubmed">26455265</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellou V, Belbasis L, Konstantinidis AK, Tzoulaki I, Evangelou E (2019) Prognostic models for outcome prediction in patients with chronic obstructive pulmonary disease: systematic review and critical appraisal. BMJ 367:l5358. https://doi.org/10.1136/bmj.l5358</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.l5358</ArticleId><ArticleId IdType="pubmed">31585960</ArticleId><ArticleId IdType="pmc">6776831</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagendran M, Chen Y, Lovejoy CA, Gordon AC, Komorowski M, Harvey H, Topol EJ, Ioannidis JPA, Collins GS, Maruthappu M (2020) Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies. BMJ 368:m689. https://doi.org/10.1136/bmj.m689</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m689</ArticleId><ArticleId IdType="pubmed">32213531</ArticleId><ArticleId IdType="pmc">7190037</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins GS, Reitsma JB, Altman DG, Moons KG (2015) Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement. Ann Intern Med 162:55&#x2013;63. https://doi.org/10.7326/M14-0697</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M14-0697</ArticleId><ArticleId IdType="pubmed">25560714</ArticleId></ArticleIdList></Reference><Reference><Citation>Debray TP, Damen JA, Snell KI, Ensor J, Hooft L, Reitsma JB, Riley RD, Moons KG (2017) A guide to systematic review and meta-analysis of prediction model performance. BMJ 356:i6460. https://doi.org/10.1136/bmj.i6460</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i6460</ArticleId><ArticleId IdType="pubmed">28057641</ArticleId></ArticleIdList></Reference><Reference><Citation>Moons KGM, Wolff RF, Riley RD, Whiting PF, Westwood M, Collins GS, Reitsma JB, Kleijnen J, Mallett S (2019) PROBAST: A tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration. Ann Intern Med 170:W1&#x2013;W33. https://doi.org/10.7326/M18-1377</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M18-1377</ArticleId><ArticleId IdType="pubmed">30596876</ArticleId></ArticleIdList></Reference><Reference><Citation>Damen JA, Hooft L, Schuit E, Debray TP, Collins GS, Tzoulaki I, Lassale CM, Siontis GC, Chiocchia V, Roberts C, Schlussel MM, Gerry S, Black JA, Heus P, van der Schouw YT, Peelen LM, Moons KG (2016) Prediction models for cardiovascular disease risk in the general population: systematic review. BMJ 353:i2416. https://doi.org/10.1136/bmj.i2416</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i2416</ArticleId><ArticleId IdType="pubmed">27184143</ArticleId><ArticleId IdType="pmc">27184143</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, Pencina MJ, Kattan MW (2010) Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 21:128&#x2013;138. https://doi.org/10.1097/EDE.0b013e3181c30fb2</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0b013e3181c30fb2</ArticleId><ArticleId IdType="pubmed">20010215</ArticleId><ArticleId IdType="pmc">3575184</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff RF, Moons KGM, Riley RD, Whiting PF, Westwood M, Collins GS, Reitsma JB, Kleijnen J, Mallett S, Groupdagger P (2019) PROBAST: a tool to assess the risk of bias and applicability of prediction model studies. Ann Intern Med 170:51&#x2013;58. https://doi.org/10.7326/M18-1376</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M18-1376</ArticleId><ArticleId IdType="pubmed">30596875</ArticleId></ArticleIdList></Reference><Reference><Citation>Jablecki CK, Berry C, Leach J (1989) Survival prediction in amyotrophic lateral sclerosis. Muscle Nerve 12:833&#x2013;841</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880121008</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng HJ, Debray TPA, Visser AE, van Eijk RPA, Rooney JPK, Calvo A, Martin S, McDermott CJ, Thompson AG, Pinto S, Kobeleva X, Rosenbohm A, Stubendorff B, Sommer H, Middelkoop BM, Dekker AM, van Vugt JJFA, van Rheenen W, Vajda A, Heverin M, Kazoka M, Hollinger H, Gromicho M, K&#xf6;rner S, Ringer TM, R&#xf6;diger A, Gunkel A, Shaw CE, Bredenoord AL, van Es MA, Corcia P, Couratier P, Weber M, Grosskreutz J, Ludolph AC, Petri S, de Carvalho M, Van Damme P, Talbot K, Turner MR, Shaw PJ, Al-Chalabi A, Chi&#xf2; A, Hardiman O, Moons KGM, Veldink JH, van den Berg LH (2018) Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol 17:423&#x2013;433. https://doi.org/10.1016/S1474-4422(18)30089-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30089-9</ArticleId><ArticleId IdType="pubmed">29598923</ArticleId></ArticleIdList></Reference><Reference><Citation>Yip CH, Evans DG, Agarwal G, Buccimazza I, Kwong A, Morant R, Prakash I, Song CY, Taib NA, Tausch C, Ung O, Meterissian S (2019) Global disparities in breast cancer genetics testing, counselling and management. World J Surg 43:1264&#x2013;1270. https://doi.org/10.1007/s00268-018-04897-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00268-018-04897-6</ArticleId><ArticleId IdType="pubmed">30610270</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngoya PS, Muhogora WE, Pitcher RD (2016) Defining the diagnostic divide: an analysis of registered radiological equipment resources in a low-income African country. Pan Afr Med J 25:99. https://doi.org/10.11604/pamj.2016.25.99.9736</Citation><ArticleIdList><ArticleId IdType="doi">10.11604/pamj.2016.25.99.9736</ArticleId><ArticleId IdType="pubmed">28292062</ArticleId><ArticleId IdType="pmc">5325496</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M-D, Little J, Gomes J, Cashman NR, Krewski D (2017) Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis. Neurotoxicology 61:101&#x2013;130. https://doi.org/10.1016/j.neuro.2016.06.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2016.06.015</ArticleId><ArticleId IdType="pubmed">27377857</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Redondo A, Dols-Icardo O, Rojas-Garc&#xed;a R, Esteban-P&#xe9;rez J, Cordero-V&#xe1;zquez P, Mu&#xf1;oz-Blanco JL, Catalina I, Gonz&#xe1;lez-Mu&#xf1;oz M, Varona L, Sarasola E, Povedano M, Sevilla T, Guerrero A, Pardo J, L&#xf3;pez de Munain A, M&#xe1;rquez-Infante C, de Rivera FJR, Pastor P, Jeric&#xf3; I, de Arcaya A&#xc1;, Mora JS, Clarim&#xf3;n J, Gonzalo-Mart&#xed;nez JF, Ju&#xe1;rez-Rufi&#xe1;n A, Atencia G, Jim&#xe9;nez-Bautista R, Mor&#xe1;n Y, Masc&#xed;as J, Hern&#xe1;ndez-Barral M, Kapetanovic S, Garc&#xed;a-Barcina M, Alcal&#xe1; C, Vela A, Ram&#xed;rez-Ramos C, Gal&#xe1;n L, P&#xe9;rez-Tur J, Quint&#xe1;ns B, Sobrido MJ, Fern&#xe1;ndez-Torr&#xf3;n R, Poza JJ, Gorostidi A, Paradas C, Villoslada P, Larrod&#xe9; P, Capablo JL, Pascual-Calvet J, Go&#xf1;i M, Morgado Y, Guitart M, Moreno-Laguna S, Rueda A, Mart&#xed;n-Estefan&#xed;a C, Cemill&#xe1;n C, Blesa R, Lle&#xf3; A (2013) Analysis of the C9orf72 gene in patients with amyotrophic lateral sclerosis in Spain and different populations worldwide. Hum Mutat 34:79&#x2013;82. https://doi.org/10.1002/humu.22211</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.22211</ArticleId><ArticleId IdType="pubmed">22936364</ArticleId></ArticleIdList></Reference><Reference><Citation>Atassi N, Berry J, Shui A, Zach N, Sherman A, Sinani E, Walker J, Katsovskiy I, Schoenfeld D, Cudkowicz M, Leitner M (2014) The PRO-ACT database: design, initial analyses, and predictive features. Neurology 83:1719&#x2013;1725. https://doi.org/10.1212/WNL.0000000000000951</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000951</ArticleId><ArticleId IdType="pubmed">25298304</ArticleId><ArticleId IdType="pmc">4239834</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal SP, Zinman L, Simpson E, McKinley J, Jackson KE, Pinto H, Kaufman P, Conwit RA, Schoenfeld D, Shefner J, Cudkowicz M (2010) Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 9:481&#x2013;488. https://doi.org/10.1016/S1474-4422(10)70068-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70068-5</ArticleId><ArticleId IdType="pubmed">20363190</ArticleId><ArticleId IdType="pmc">3071495</ArticleId></ArticleIdList></Reference><Reference><Citation>Groenwold RH, Moons KG, Pajouheshnia R, Altman DG, Collins GS, Debray TP, Reitsma JB, Riley RD, Peelen LM (2016) Explicit inclusion of treatment in prognostic modeling was recommended in observational and randomized settings. J Clin Epidemiol 78:90&#x2013;100. https://doi.org/10.1016/j.jclinepi.2016.03.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2016.03.017</ArticleId><ArticleId IdType="pubmed">27045189</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;ffner R, Zach N, Norel R, Hawe J, Schoenfeld D, Wang L, Li G, Fang L, MacKey L, Hardiman O, Cudkowicz M, Sherman A, Ertaylan G, Grosse-Wentrup M, Hothorn T, Van Ligtenberg J, MacKe JH, Meyer T, Sch&#xf6;lkopf B, Tran L, Vaughan R, Stolovitzky G, Leitner ML (2015) Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression. Nat Biotechnol 33:51&#x2013;57. https://doi.org/10.1038/nbt.3051</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.3051</ArticleId><ArticleId IdType="pubmed">25362243</ArticleId></ArticleIdList></Reference><Reference><Citation>Kueffner R, Zach N, Bronfeld M, Norel R, Atassi N, Balagurusamy V, Di Camillo B, Chio A, Cudkowicz M, Dillenberger D, Garcia-Garcia J, Hardiman O, Hoff B, Knight J, Leitner ML, Li G, Mangravite L, Norman T, Wang L, Alkallas R, Anghel C, Avril J, Bacardit J, Balser B, Balser J, Bar-Sinai Y, Ben-David N, Ben-Zion E, Bliss R, Cai J, Chernyshev A, Chiang J-H, Chicco D, Corriveau BAN, Dai J, Deshpande Y, Desplats E, Durgin JS, Espiritu SMG, Fan F, Fevrier P, Fridley BL, Godzik A, Golinska A, Gordon J, Graw S, Guo Y, Herpelinck T, Hopkins J, Huang B, Jacobsen J, Jahandideh S, Jeon J, Ji W, Jung K, Karanevich A, Koestler DC, Kozak M, Kurz C, Lalansingh C, Larrieu T, Lazzarini N, Lerner B, Lesinski W, Liang X, Lin X, Lowe J, Mackey L, Meier R, Min W, Mnich K, Nahmias V, Noel-MacDonnell J, O&#x2019;Donnell A, Paadre S, Park J, Polewko-Klim A, Raghavan R, Rudnicki W, Saghapour E, Salomond J-B, Sankaran K, Sendorek D, Sharan V, Shiah Y-J, Sirois J-K, Sumanaweera DN, Usset J, Vang YS, Vens C, Wadden D, Wang D, Wong WC, Xie X, Xu Z, Yang H-T, Yu X, Zhang H, Zhang L, Zhang S, Zhu S, Xiao J, Fang W-C, Peng J, Yang C, Chang H-J, Stolovitzky G, Consortium ALSS (2019) Stratification of amyotrophic lateral sclerosis patients: a crowdsourcing approach. Sci Rep 9:690. https://doi.org/10.1038/s41598-018-36873-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-36873-4</ArticleId><ArticleId IdType="pubmed">30679616</ArticleId><ArticleId IdType="pmc">6345935</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, Hardiman O, Kollewe K, Morrison KE, Petri S, Pradat PF, Silani V, Tomik B, Wasner M, Weber M (2012) EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)&#x2013;revised report of an EFNS task force. Eur J Neurol 19:360&#x2013;375. https://doi.org/10.1111/j.1468-1331.2011.03501.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2011.03501.x</ArticleId><ArticleId IdType="pubmed">21914052</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller RG, Rosenberg JA, Gelinas DF, Mitsumoto H, Newman D, Sufit R, Borasio GD, Bradley WG, Bromberg MB, Brooks BR, Kasarskis EJ, Munsat TL, Oppenheimer EA (1999) Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology 52:1311&#x2013;1323. https://doi.org/10.1212/wnl.52.7.1311</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.52.7.1311</ArticleId><ArticleId IdType="pubmed">10227612</ArticleId></ArticleIdList></Reference><Reference><Citation>Neurology JSo (2013) ALS clinical practice guidelines 2013. Nankodo Co Ltd, Tokyo</Citation></Reference><Reference><Citation>Tramacere I, Dalla Bella E, Chi&#xf2; A, Mora G, Filippini G, Lauria G (2015) The MITOS system predicts long-term survival in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 86:1180&#x2013;1185. https://doi.org/10.1136/jnnp-2014-310176</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2014-310176</ArticleId><ArticleId IdType="pubmed">25886781</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche JC, Rojas-Garcia R, Scott KM, Scotton W, Ellis CE, Burman R, Wijesekera L, Turner MR, Leigh PN, Shaw CE, Al-Chalabi A (2012) A proposed staging system for amyotrophic lateral sclerosis. Brain 135:847&#x2013;852. https://doi.org/10.1093/brain/awr351</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr351</ArticleId><ArticleId IdType="pubmed">22271664</ArticleId><ArticleId IdType="pmc">3286327</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Hammond ER, Mora G, Bonito V, Filippini G (2015) Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 86:38&#x2013;44. https://doi.org/10.1136/jnnp-2013-306589</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-306589</ArticleId><ArticleId IdType="pubmed">24336810</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakore NJ, Lapin BR, Kinzy TG, Pioro EP (2018) Deconstructing progression of amyotrophic lateral sclerosis in stages: a Markov modeling approach. Amyotroph Lateral Scler Frontotemporal Degener 19:483&#x2013;494. https://doi.org/10.1080/21678421.2018.1484925</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1484925</ArticleId><ArticleId IdType="pubmed">30001159</ArticleId></ArticleIdList></Reference><Reference><Citation>Grollemund V, Le Chat G, Secchi-Buhour MS, Delbot F, Pradat-Peyre JF, Bede P, Pradat PF (2021) Manifold learning for amyotrophic lateral sclerosis functional loss assessment: Development and validation of a prognosis model. J Neurol 268:825&#x2013;850. https://doi.org/10.1007/s00415-020-10181-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10181-2</ArticleId><ArticleId IdType="pubmed">32886252</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Burgh HK, Schmidt R, Westeneng HJ, de Reus MA, van den Berg LH, van den Heuvel MP (2017) Deep learning predictions of survival based on MRI in amyotrophic lateral sclerosis. Neuroimage Clin 13:361&#x2013;369. https://doi.org/10.1016/j.nicl.2016.10.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2016.10.008</ArticleId><ArticleId IdType="pubmed">28070484</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Spinelli EG, Riva N, Fontana A, Basaia S, Canu E, Castelnovo V, Falzone Y, Carrera P, Comi G, Filippi M (2019) Survival prediction models in motor neuron disease. Eur J Neurol 26:1143&#x2013;1152. https://doi.org/10.1111/ene.13957</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13957</ArticleId><ArticleId IdType="pubmed">30920076</ArticleId></ArticleIdList></Reference><Reference><Citation>Bock M, Duong YN, Kim A, Allen I, Murphy J, Lomen-Hoerth C (2017) Progression and effect of cognitive-behavioral changes in patients with amyotrophic lateral sclerosis. Neurol Clin Pract 7:488&#x2013;498. https://doi.org/10.1212/CPJ.0000000000000397</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CPJ.0000000000000397</ArticleId><ArticleId IdType="pubmed">29431172</ArticleId><ArticleId IdType="pmc">5800712</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Pagani E, Petrolini M, Sormani MP, Caputo D, Perini M, Prelle A, Salvi F, Filippi M (2010) MRI predictors of long-term evolution in amyotrophic lateral sclerosis. Eur J Neurosci 32:1490&#x2013;1496. https://doi.org/10.1111/j.1460-9568.2010.07445.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2010.07445.x</ArticleId><ArticleId IdType="pubmed">21044177</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Calvo A, Bovio G, Canosa A, Bertuzzo D, Galmozzi F, Cugnasco P, Clerico M, De Mercanti S, Bersano E, Cammarosano S, Ilardi A, Manera U, Moglia C, Sideri R, Marinou K, Bottacchi E, Pisano F, Cantello R, Mazzini L, Mora G (2014) Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study. JAMA Neurol 71:1134&#x2013;1142. https://doi.org/10.1001/jamaneurol.2014.1129</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.1129</ArticleId><ArticleId IdType="pubmed">25048026</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S, Nicholson K, Chan J, Shui A, Schoenfeld D, Sherman A, Berry J, Cudkowicz M, Atassi N (2018) Urate levels predict survival in amyotrophic lateral sclerosis: analysis of the expanded Pooled Resource Open-Access ALS clinical trials database. Muscle Nerve 57:430&#x2013;434. https://doi.org/10.1002/mus.25950</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.25950</ArticleId><ArticleId IdType="pubmed">28857199</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar M, Zhang L, Wang L, Granit V, Statland J, Barohn R, Swenson A, Ravits J, Jackson C, Burns TM, Trivedi J, Pioro EP, Caress J, Katz J, McCauley JL, Rademakers R, Malaspina A, Ostrow LW, Wuu J (2020) Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS. Neurology 95:e59&#x2013;e69. https://doi.org/10.1212/WNL.0000000000009559</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009559</ArticleId><ArticleId IdType="pubmed">32385188</ArticleId><ArticleId IdType="pmc">7371380</ArticleId></ArticleIdList></Reference><Reference><Citation>Poesen K, Van Damme P (2018) Diagnostic and prognostic performance of neurofilaments in ALS. Front Neurol 9:1167. https://doi.org/10.3389/fneur.2018.01167</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.01167</ArticleId><ArticleId IdType="pubmed">30713520</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee CT, Chiu YW, Wang KC, Hwang CS, Lin KH, Lee IT, Tsai CP (2013) Riluzole and prognostic factors in amyotrophic lateral sclerosis long-term and short-term survival: a population-based study of 1149 cases in Taiwan. J Epidemiol 23:35&#x2013;40. https://doi.org/10.2188/jea.je20120119</Citation><ArticleIdList><ArticleId IdType="doi">10.2188/jea.je20120119</ArticleId><ArticleId IdType="pubmed">23117224</ArticleId><ArticleId IdType="pmc">3700231</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrioli J, Malerba SA, Beghi E, Fini N, Fasano A, Zucchi E, De Pasqua S, Guidi C, Terlizzi E, Sette E, Ravasio A, Casmiro M, Salvi F, Liguori R, Zinno L, Handouk Y, Rizzi R, Borghi A, Rinaldi R, Medici D, Santangelo M, Granieri E, Mussuto V, Aiello M, Ferro S, Vinceti M (2018) Riluzole and other prognostic factors in ALS: a population-based registry study in Italy. J Neurol 265:817&#x2013;827. https://doi.org/10.1007/s00415-018-8778-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-8778-y</ArticleId><ArticleId IdType="pubmed">29404735</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown FS, Glasmacher SA, Kearns PKA, MacDougall N, Hunt D, Connick P, Chandran S (2020) Systematic review of prediction models in relapsing remitting multiple sclerosis. PLoS ONE 15:e0233575. https://doi.org/10.1371/journal.pone.0233575</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0233575</ArticleId><ArticleId IdType="pubmed">32453803</ArticleId><ArticleId IdType="pmc">7250448</ArticleId></ArticleIdList></Reference><Reference><Citation>Jampathong N, Laopaiboon M, Rattanakanokchai S, Pattanittum P (2018) Prognostic models for complete recovery in ischemic stroke: a systematic review and meta-analysis. BMC Neurol 18:26. https://doi.org/10.1186/s12883-018-1032-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-018-1032-5</ArticleId><ArticleId IdType="pubmed">29523104</ArticleId><ArticleId IdType="pmc">5845155</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyerberg EW (2019) Clinical prediction models: a practical approach to development, validation, and updating, 2nd edn. In: Springer Nature Switzerland</Citation></Reference><Reference><Citation>Grollemund V, Chat GL, Secchi-Buhour MS, Delbot F, Pradat-Peyre JF, Bede P, Pradat PF (2020) Development and validation of a 1-year survival prognosis estimation model for amyotrophic lateral sclerosis using manifold learning algorithm UMAP. Sci Rep 10:13378. https://doi.org/10.1038/s41598-020-70125-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-70125-8</ArticleId><ArticleId IdType="pubmed">32770027</ArticleId><ArticleId IdType="pmc">7414917</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins GS, Moons KGM (2019) Reporting of artificial intelligence prediction models. Lancet 393:1577&#x2013;1579. https://doi.org/10.1016/S0140-6736(19)30037-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(19)30037-6</ArticleId><ArticleId IdType="pubmed">31007185</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>